A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if nesiritide (a human B-type natriuretic
peptide/hBNP) as compared to placebo, plus the usual treatment for acute decompensated heart
failure, helps to improve breathing difficulties, reduce heart failure readmissions to
hospitals, and helps patients live longer.